Malignant peripheral nerve sheath tumors: clinicopathological aspects, expression of p53 and survival
- PMID: 22948467
- PMCID: PMC3416905
- DOI: 10.6061/clinics/2012(08)18
Malignant peripheral nerve sheath tumors: clinicopathological aspects, expression of p53 and survival
Conflict of interest statement
No potential conflict of interest was reported.
Figures

Similar articles
-
Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors.Neuro Oncol. 2009 Oct;11(5):514-28. doi: 10.1215/15228517-2008-127. Epub 2009 Jan 30. Neuro Oncol. 2009. PMID: 19182148 Free PMC article.
-
Malignant peripheral nerve sheath tumours: high Ki67 labelling index is the significant prognostic indicator.Histopathology. 2001 Aug;39(2):187-97. doi: 10.1046/j.1365-2559.2001.01176.x. Histopathology. 2001. PMID: 11493336
-
Immunohistochemical assessment of cyclin D1 and p53 is associated with survival in childhood malignant peripheral nerve sheath tumor.Cancer Biomark. 2019;24(3):351-361. doi: 10.3233/CBM-181572. Cancer Biomark. 2019. PMID: 30883338
-
Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors: II. The role of dysregulated growth factor signaling.J Neuropathol Exp Neurol. 2005 Jan;64(1):1-9. doi: 10.1093/jnen/64.1.1. J Neuropathol Exp Neurol. 2005. PMID: 15715079 Review.
-
Toward Understanding the Mechanisms of Malignant Peripheral Nerve Sheath Tumor Development.Int J Mol Sci. 2021 Aug 10;22(16):8620. doi: 10.3390/ijms22168620. Int J Mol Sci. 2021. PMID: 34445326 Free PMC article. Review.
Cited by
-
Tumor expression of survivin, p53, cyclin D1, osteopontin and fibronectin in predicting the response to neo-adjuvant chemotherapy in children with advanced malignant peripheral nerve sheath tumor.J Cancer Res Clin Oncol. 2018 Mar;144(3):519-529. doi: 10.1007/s00432-018-2580-1. Epub 2018 Jan 13. J Cancer Res Clin Oncol. 2018. PMID: 29332262 Free PMC article.
-
Multifocal malignant peripheral nerve sheath tumor in patients with neurofibromatosis type I: Report of two cases and review of literature.Surg Neurol Int. 2023 Jul 28;14:261. doi: 10.25259/SNI_213_2023. eCollection 2023. Surg Neurol Int. 2023. PMID: 37560595 Free PMC article.
-
Breast cancer and neurofibromatosis type 1: a diagnostic challenge in patients with a high number of neurofibromas.BMC Cancer. 2015 Mar 26;15:183. doi: 10.1186/s12885-015-1215-z. BMC Cancer. 2015. PMID: 25885768 Free PMC article.
-
Surgical Treatment and Targeted Therapy for a Large Metastatic Malignant Peripheral Nerve Sheath Tumor: A Case Report and Literature Review.Life (Basel). 2024 Dec 12;14(12):1648. doi: 10.3390/life14121648. Life (Basel). 2024. PMID: 39768355 Free PMC article.
-
Retroperitoneal Malignant Peripheral Nerve Sheath Tumour: A Rare Case Report.J Clin Diagn Res. 2015 Sep;9(9):ED09-11. doi: 10.7860/JCDR/2015/14169.6481. Epub 2015 Sep 1. J Clin Diagn Res. 2015. PMID: 26500915 Free PMC article.
References
-
- Scheithauer BW, Woodruff JM, Erlandson RA.Primary malignant tumors of peripheral nerve Tumors of the peripheral nervous system. Washington, DC: Amer Registry of Pathology; 1999. p.303–72.
-
- Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer. 1986;57(10):2006–21. - PubMed
-
- Friedman JM, Gutmann DH, Maccollin M, Riccardi VM. Johns Hopkins University Press; 1999. Neurofibromatosis: phenotype, natural history, and pathogenesis.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous